Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William M Bonner

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Nature Communications|February 16, 2016
The histone variant H2A.X is a regulator of the epithelial-mesenchymal transitionUrbain Weyemi, Christophe E Redon, Rohini Choudhuri, et al.
Radiology|April 16, 2016
Effects of Breast Shielding during Heart Imaging on DNA Double-Strand-Break Levels: A Prospective Randomized Controlled TrialMichael K Cheezum, Christophe E Redon, Allison S Burrell, et al.
EMBO Reports|June 27, 2009
Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaksOlivier Sordet, Christophe E Redon, Josée Guirouilh-Barbat, et al.
Molecular Cell|December 19, 2017
Replication Stress Shapes a Protective Chromatin Environment across Fragile Genomic RegionsJeongkyu Kim, David Sturgill, Robin Sebastian, et al.
Free Radical Biology & Medicine|March 3, 2010
DNA-PKcs deficiency leads to persistence of oxidatively induced clustered DNA lesions in human tumor cellsPrakash Peddi, Charles W Loftin, Jennifer S Dickey, et al.
The Journal of Biological Chemistry|March 28, 2003
Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexesTakahisa Furuta, Haruyuki Takemura, Zhi-Yong Liao, et al.
Anti-Cancer Drugs|February 9, 2018
Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lungSanjeeve Balasubramaniam, Christophe E Redon, Cody J Peer, et al.
Nature Cell Biology|November 26, 2002
DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1Oscar Fernandez-Capetillo, Hua-Tang Chen, Arkady Celeste, et al.
Plos One|February 4, 2017
Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assayJiuping Ji, Yiping Zhang, Christophe E Redon, et al.
Nature|December 12, 2001
AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switchingSimone Petersen, Rafael Casellas, Bernardo Reina-San-Martin, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Nature Communications|February 16, 2016
The histone variant H2A.X is a regulator of the epithelial-mesenchymal transitionUrbain Weyemi, Christophe E Redon, Rohini Choudhuri, et al.
Radiology|April 16, 2016
Effects of Breast Shielding during Heart Imaging on DNA Double-Strand-Break Levels: A Prospective Randomized Controlled TrialMichael K Cheezum, Christophe E Redon, Allison S Burrell, et al.
EMBO Reports|June 27, 2009
Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaksOlivier Sordet, Christophe E Redon, Josée Guirouilh-Barbat, et al.
Molecular Cell|December 19, 2017
Replication Stress Shapes a Protective Chromatin Environment across Fragile Genomic RegionsJeongkyu Kim, David Sturgill, Robin Sebastian, et al.
Free Radical Biology & Medicine|March 3, 2010
DNA-PKcs deficiency leads to persistence of oxidatively induced clustered DNA lesions in human tumor cellsPrakash Peddi, Charles W Loftin, Jennifer S Dickey, et al.
The Journal of Biological Chemistry|March 28, 2003
Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexesTakahisa Furuta, Haruyuki Takemura, Zhi-Yong Liao, et al.
Anti-Cancer Drugs|February 9, 2018
Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lungSanjeeve Balasubramaniam, Christophe E Redon, Cody J Peer, et al.
Nature Cell Biology|November 26, 2002
DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1Oscar Fernandez-Capetillo, Hua-Tang Chen, Arkady Celeste, et al.
Plos One|February 4, 2017
Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assayJiuping Ji, Yiping Zhang, Christophe E Redon, et al.
Nature|December 12, 2001
AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switchingSimone Petersen, Rafael Casellas, Bernardo Reina-San-Martin, et al.
Pageof 8